Non-Peptide Research Research
Beyond Peptides. Advanced Research Compounds.
Selective androgen receptor modulators and other novel research compounds studied for their unique pharmacological profiles.
11
Research Compounds
26
Scientific References
Monthly
Updated
Research Snapshot
Evidence Summary
Research Areas
Mechanisms
Research Status
LGD-4033 and Ostarine have Phase I/II clinical data. Cardarine development paused. Others in preclinical research stages.
Evidence Base
11
Compounds
26+
References
Research Overview
What this field
investigates
What we research
The Non-Peptide Research category covers selective androgen receptor modulators (SARMs) and other novel research compounds studied for their unique pharmacological profiles — distinct from peptide-based mechanisms.
How compounds are grouped
Compounds are grouped by class: anabolic SARMs (RAD-140, LGD-4033, Ostarine), metabolic modulators (Cardarine, SR-9009), and myostatin inhibitors (YK-11). Each offers tissue-selective activity without the broad systemic effects of traditional androgens.
Research considerations
SARMs are investigational compounds. Some have reached Phase I/II clinical trials (LGD-4033, Enobosarm). None are FDA-approved for general use. Cardiovascular, hepatic, and endocrine safety data is still being characterized. These are research chemicals only.
Research Category
All Compounds
MK-677
Ibutamoren — Oral GH Secretagogue
MK-677 (Ibutamoren) is a non-peptide, orally active growth hormone secretagogue and selective agonist of the g...
RAD-140
Testolone — Selective Androgen Receptor Modulator
RAD-140 (Testolone) is a non-steroidal selective androgen receptor modulator (SARM) developed by Radius Health...
LGD-4033
Ligandrol — The Muscle-Selective SARM
LGD-4033 (Ligandrol, VK5211) is a non-steroidal oral SARM developed by Ligand Pharmaceuticals and later licens...
Cardarine
GW-501516 — PPARδ Agonist and Metabolic Modulator
Cardarine (GW-501516, GW1516) is a PPARδ (peroxisome proliferator-activated receptor delta) agonist originally...
Ostarine
MK-2866 — The Foundational SARM
Ostarine (MK-2866, Enobosarm) is one of the first SARMs to enter human clinical trials, developed by GTx Inc. ...
SR-9009
Stenabolic — REV-ERB Agonist and Circadian Modulator
SR-9009 (Stenabolic) is a synthetic REV-ERBα/β agonist developed at the Scripps Research Institute. REV-ERB pr...
YK-11
The Myostatin Inhibitor SARM
YK-11 is a steroidal selective androgen receptor modulator and putative myostatin inhibitor. Discovered by Kan...
Andarine
S-4 — The First-Generation Clinical SARM
Andarine (S-4, GTx-007) is a non-steroidal selective androgen receptor modulator developed by GTx Inc. as one ...
S23
The High-Affinity SARM for Contraceptive Research
S23 is a non-steroidal selective androgen receptor modulator developed by GTX Inc. with exceptionally high bin...
AICAR
The Exercise-Mimetic AMPK Activator
AICAR (5-Aminoimidazole-4-carboxamide ribonucleotide, Acadesine) is a nucleotide analogue that activates AMP-a...
GW-0742
The Next-Generation PPARδ Agonist
GW-0742 is a potent and selective PPARδ (peroxisome proliferator-activated receptor delta) agonist developed b...
Knowledge Base
Research Articles
Educational guides and mechanism explanations relevant to non-peptide research research.
RAD-140 (Testolone): Selective Anabolic Activity
Examining RAD-140's tissue-selective androgen receptor binding and its Phase I breast cancer research.
Cardarine (GW501516): PPARδ and Exercise Mimetics
How Cardarine activates PPARδ to drive fatty acid oxidation and its implications for endurance research.
LGD-4033 (Ligandrol): Phase I Clinical Data
Viking Therapeutics' Phase I trial showing dose-dependent lean mass gains and the VK5211 hip fracture study.
Still not sure?
Use our interactive Research Navigator to discover compounds commonly investigated for your specific research goals. Educational only — no products, no pricing.
Start Research NavigatorExplore More